SARAH LINDSAY: Open Payments
NPI 1740483676 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 66 payments from 20 companies in 2025. Trend: 2023 $488 · 2024 $1,546 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $467 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $407 |
| Madrigal Pharmaceuticals | 3 | $174 |
| Janssen Biotech, Inc. | 4 | $87 |
| Exact Sciences Corporation | 3 | $71 |
| United Therapeutics Corporation | 2 | $66 |
| Aimmune Therapeutics, Inc. | 4 | $64 |
| Baxter Healthcare | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $60 |
| VIVUS LLC | 2 | $50 |
Products named: ENTYVIO, REZDIFFRA, SKYRIZI, CUVITRU, RINVOQ, The Cologuard Plus Collection Kit, TREMFYA, Tyvaso.
Industry payments across FL — which companies pay providers there.
